WASHINGTON, D.C. — President Donald J. Trump today announced the launch of a sweeping new domestic policy initiative titled “The Great Healthcare Plan,” a proposal designed to fundamentally restructure how Americans pay for medical care and prescription drugs. Speaking from the White House on Thursday, January 15, 2026, the President outlined a strategy centered on diverting federal funds away from large insurance carriers and delivering financial resources directly to American households.
The announcement comes as the administration seeks to address rising healthcare costs and the expiration of subsidies associated with the Affordable Care Act. Under the new framework, the President stated that the federal government would cease “extra taxpayer-funded subsidy payments” currently allocated to major insurance corporations. Instead, those funds are intended to be distributed directly to eligible citizens, allowing individuals to purchase health coverage of their choice.
“The government is going to pay the money directly to you,” President Trump said during the unveiling. “It goes to you, and then you take the money and buy your own healthcare… the big insurance companies lose and the people of our country win.”
A central pillar of the plan involves a significant overhaul of prescription drug pricing. The administration seeks to codify “Most-Favored-Nation” pricing standards, a policy that mandates pharmaceutical companies charge the United States no more than the lowest price paid by other developed nations for the same medications. Officials project that this measure could reduce the cost of certain prescription drugs by as much as 80 to 90 percent.
To facilitate these changes, the White House introduced “Trumprx.gov,” a new platform where patients can access these discounted medications. The administration claims that prices for many drugs on the platform could be slashed by hundreds of percentage points starting immediately. “Your prescription drugs will come way, way down,” Trump remarked, emphasizing that American patients would no longer pay premiums significantly higher than the global average.
Beyond direct payments and drug pricing, “The Great Healthcare Plan” proposes strict transparency measures for the insurance industry. The plan includes a “Plain English” standard, requiring insurers to simplify policy documents and eliminate complex industry jargon. This provision aims to make coverage details, rate comparisons, and claim denial frequencies easily understandable for the average consumer.
The proposal also targets the “middlemen” of the healthcare industry by calling for an end to kickbacks paid by pharmacy benefit managers (PBMs). The White House asserts that eliminating these payments will further drive down insurance premiums. Citing data from the Congressional Budget Office, administration officials stated that the plan’s cost-sharing reduction program is projected to save taxpayers at least $36 billion and reduce premiums for common healthcare plans by more than 10 percent.
The unveiling of the plan follows months of executive actions and signaling from the Trump administration regarding a move toward a more market-driven healthcare model. By grandfathering in existing voluntary pricing deals with the Department of Health and Human Services and expanding access to over-the-counter drugs, the plan aims to increase competition and reduce the necessity for costly doctor visits for routine medications.
As the proposal moves to Congress, the administration is urging lawmakers to enact the necessary legislation to fully implement these reforms. “Instead of putting the needs of big corporations and special interests first, our plan finally puts you first,” President Trump concluded.
* whitehouse.gov
* fingerlakes1.com
* seekingalpha.com
* whitehouse.gov
* youtube.com
* youtube.com
* pwc.com
* aamc.org
* whitehouse.gov
